CD274 and neoplasm: Qin et al. 2024 demonstrated in his study a modified strain of E. coli Nissle 1917 (EcN) that co-expresses nanobodies against programmed death-ligand 1 (PD-L1) and CD9, a tetraspanin protein enriched in tumor-derived exosomes (TDEs).